Company intelligence / Profile preview
Crescent Biopharma
Waltham, MA, USAcrescentbiopharma.com ↗
- Ownership
- Public · CBIO
- Development stage
- Preclinical
01
Overview
Crescent Biopharma is a biotechnology company focused on developing next-generation oncology therapeutics using precision-engineered biologic molecules. Its pipeline includes a lead bispecific antibody program targeting PD‑1 x VEGF designed to improve efficacy over current standards like pembrolizumab, as well as two novel ADC programs leveraging topoisomerase inhibitor payloads. The company’s assets originated from Paragon Therapeutics’ antibody discovery engine and are supported by significant venture funding post-merger with GlycoMimetics. Early clinical proof-of-concept data are expected in solid tumor patients by the second half of 2026.
- Therapeutic areas
- Oncology
- Modalities
- Bispecific antibodiesAntibody-drug conjugates (ADCs)Precision-engineered biologics
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Financials
- Market cap
- $480.6M
- Total revenue
- $10.8M
- Enterprise value
- $310.5M
Beyond the preview
Go deeper on Crescent Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crescent Biopharma.